Activation of Rat Alveolar Macrophage-Derived Latent Transforming Growth Factor β-1 by Plasmin Requires Interaction with Thrombospondin-1 and its Cell Surface Receptor, CD36

This publication has 54 references indexed in Scilit:

• Role of Carbohydrate Structures in the Binding of β1-Latency-Associated Peptide to Ligands
  Biochemistry, 1997
• Regulation of Monocyte CD36 and Thrombospondin-1 Expression by Soluble Mediators
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Proteolysis of thrombospondin during cathepsin‐G‐induced platelet aggregation: functional role of the 165‐kDa carboxy‐terminal fragment
  FEBS Letters, 1996
• The role of thrombospondin‐1 in tumor progression and angiogenesis
  BioEssays, 1996
• Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite‐induced pulmonary inflammation and fibrosis
  Journal of Toxicology and Environmental Health, 1995
• Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells
  Cancer, 1995
• Transforming growth factor beta: the good, the bad, and the ugly.
  The Journal of Experimental Medicine, 1994
• Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells
  Journal of Cellular Physiology, 1993
• Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin.
  The Journal of cell biology, 1993
• 12-o-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases. High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G.
  Journal of Clinical Investigation, 1986